We confirmed the ~50% reduction of KLK7 mRNA expression in the brains of Japanese AD patients (Fig 2) (Miyashita et al, 2014) in good correlation with Braak NFT stage (Appendix Fig S2). Here, KLK7 is linked to Alzheimer disease.